VOYA Investment Management’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,938
Closed -$72K 2916
2023
Q2
$72K Buy
2,938
+953
+48% +$24.8K ﹤0.01% 2865
2023
Q1
$62.1K Hold
1,985
﹤0.01% 2772
2022
Q4
$140K Hold
1,985
﹤0.01% 2676
2022
Q3
$171K Buy
1,985
+247
+14% +$24K ﹤0.01% 2652
2022
Q2
$144K Buy
1,738
+392
+29% +$34.6K ﹤0.01% 2523
2022
Q1
$224K Hold
1,346
﹤0.01% 2310
2021
Q4
$225K Sell
1,346
-156
-10% -$17.6K ﹤0.01% 2439
2021
Q3
$130K Hold
1,502
﹤0.01% 2681
2021
Q2
$82K Buy
1,502
+2
+0.1% +$114 ﹤0.01% 2794
2021
Q1
$89K Hold
1,500
﹤0.01% 2688
2020
Q4
$78K Buy
1,500
+445
+42% +$24.8K ﹤0.01% 2606
2020
Q3
$51K Hold
1,055
﹤0.01% 2433
2020
Q2
$55K Sell
1,055
-368
-26% -$18.6K ﹤0.01% 2440
2020
Q1
$62K Buy
1,423
+187
+15% +$7.61K ﹤0.01% 2452
2019
Q4
$50K Buy
+1,236
New +$38K ﹤0.01% 2639

Other funds holding KZR

VOYA Investment Management's KZR Position: Q3 2023 in Review

VOYA Investment Management sold out of Kezar Life Sciences (KZR) in Q3 2023, closing a stake of 2,938 shares — an estimated $72K sold.

VOYA Investment Management first reported a position in KZR in Q4 2019 and held it in 15 quarters. The position peaked at $225K in Q4 2021. 82 funds tracked by Wall St. Rank hold KZR as of Q3 2023.

  • VOYA Investment Management reported no remaining Kezar Life Sciences position as of Q3 2023 after selling out during the quarter.
  • VOYA Investment Management sold 2,938 Kezar Life Sciences shares in Q3 2023, an estimated $72K.
  • VOYA Investment Management first reported a position in Kezar Life Sciences in Q4 2019 and held it in 15 quarters.
  • VOYA Investment Management's Kezar Life Sciences position peaked at $225K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2023.

Based on VOYA Investment Management's 13F filing for Q3 2023, filed 14 Nov 2023.